Roche DRC Multi-center, non-randomized, open-label, multiple ascending dose study to investigate the safety, tolerability,pharmacokinetics, and pharmacodynamics of RO7200394 following intravitreal administration in patients with nAMD
Research Grant
Administered By
Ophthalmology
Awarded By
Hoffman-La Roche, Inc.
Start Date
February 1, 2019
End Date
January 30, 2023
Administered By
Ophthalmology
Awarded By
Hoffman-La Roche, Inc.
Start Date
February 1, 2019
End Date
January 30, 2023